Human microdosing Phase 0 studies are used to obtain key information in early drug development concerning a drug's pharmacokinetic and limited pharmacodynamic parameters. Developed as a method in the 2000s, microdosing has become part of the critical path of drug development. Microdosing studies can assist in drug candidate selection prior to going into expensive Phase I studies. This chapter...